Targeting the dermis for melasma maintenance treatment

Hee Jeong Han,Jin Cheol Kim,Young Joon Park,Hee Young Kang

DOI: https://doi.org/10.1038/s41598-023-51133-w

IF: 4.6

2024-01-11

Scientific Reports

Abstract:Melasma relapse is almost common after discontinuation of conventional treatment. Recent studies suggesting that photoaging dermis is the main pathomechanism of melasma, emphasize the dermal targeting therapy. We investigated maintenance effect of microneedling radiofrequency (RF) for melasma treatment. Subjects with melasma were administered oral tranexamic acid and triple combination cream for 2 months and a randomly assigned half face was treated with RF. After discontinuation of conventional therapy, the half face RF continued monthly over 6 months. Modified melasma area severity index (mMASI) score and L* value by a chromameter were collected monthly. Fifteen subjects were enrolled and eleven completed the 8-month study. At 2nd month of conventional therapy, all subjects showed improvement with a 64% reduction in mMASI score. With continuous RF treatment, the improvement was well maintained; whereas in untreated side, the Δ L* gradually decreased, returning to the baseline after the conventional therapy ended. The continuous microneedling RF therapy is beneficial in maintaining the conventional therapy of melasma suggesting the protective effect of dermal targeting therapy in melasma development.

multidisciplinary sciences

What problem does this paper attempt to address?

This paper discusses the maintenance treatment of melasma, a skin disorder characterized by pigmentation. The study found that conventional treatment methods (oral tranexamic acid and triple therapy cream) often lead to relapse after discontinuation. Recent research has suggested that photoaging of the dermis may be the main pathological mechanism of melasma, therefore the focus of this paper is dermal-targeted therapy. The study employed microneedling radiofrequency (RF) therapy as a maintenance treatment.

During the two-month preliminary treatment, all patients received oral tranexamic acid and used the triple therapy cream. One side of the face was randomly assigned to receive RF treatment. After discontinuing the conventional treatment, RF treatment continued once a month for six months. The results showed that RF treatment helped maintain improvement, while the untreated facial area gradually returned to the baseline condition, with intensified pigmentation.

The paper also mentions that melasma is considered to be one of the phenotypes of photoaging, with complex pathogenic mechanisms including collagen aging, increased vascularity, and fibroblast proliferation. Dermal-targeted treatments such as RF microneedling may improve aging dermis and reduce pigmentation signaling, thus contributing to the prevention of melasma relapse. However, RF microneedling therapy did not demonstrate significant advantages over conventional treatment, but it better maintained treatment efficacy.

In conclusion, this study emphasizes the potential benefits of dermal-targeted therapy in the maintenance treatment of melasma, providing new strategies for preventing disease recurrence.